Fixed Lingual Mandibular Growth Modificator (FLMGM)
Primary Purpose
Class II Division 1 Malocclusion, Retrognathic Mandible
Status
Completed
Phase
Not Applicable
Locations
Syrian Arab Republic
Study Type
Interventional
Intervention
Fixed Lingual Mandibular Growth Modificator (FLMGM)
Sponsored by
About this trial
This is an interventional treatment trial for Class II Division 1 Malocclusion focused on measuring Class II division 1 malocclusion, Dentofacial orthopedics, Fixed Lingual Mandibular Growth Modificator (FLMGM)
Eligibility Criteria
Inclusion Criteria:
Before treatment, each patient fulfilled the following criteria:
- Cl II/1 malocclusion with an overjet greater than 4 mm.
- Mild to moderate Class II Skeletal pattern (A-N-B > 4°) with retrognathic mandible (S-N-B < 76°).
- Growth potential. Fishman skeletal maturation indicator (SMI) method28 was used to assess the hand-wrist radiographs, and only patients in the peak of the pubertal growth spurt, which occurs on average between SMIs 4 to 7,29 at the beginning of the treatment/observation period were invited.
Exclusion Criteria:
-
Sites / Locations
- Department of Orthodontics, School of Dentistry, University of Damascus
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
FLMGM Treatment Group
Untreated Class II Control Group
Arm Description
Outcomes
Primary Outcome Measures
Total Mandibular Length (Co-Gn)
Secondary Outcome Measures
Overjet Reduction
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01853137
Brief Title
Fixed Lingual Mandibular Growth Modificator
Acronym
FLMGM
Official Title
A Prospective Controlled Evaluation of Class II Division 1 Malocclusions Treated With Fixed Lingual Mandibular Growth Modificator (FLMGM)
Study Type
Interventional
2. Study Status
Record Verification Date
October 2020
Overall Recruitment Status
Completed
Study Start Date
May 2009 (undefined)
Primary Completion Date
July 2011 (Actual)
Study Completion Date
December 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Damascus University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The current trial was designed to investigate the possible initial net skeletal and dental effects of treatment with FLMGM by a comparative evaluation of treated and untreated Cl II/1 malocclusion subjects. The null hypothesis stated that there were no significant differences in dentofacial changes between FLMGM group and control group.
Detailed Description
The study was prospective controlled clinical trial conducted at the department of Orthodontics, between May/2009 and June/2011. The protocol of study was approved by the council of scientific research and postgraduate studies.
The original study sample included 43 patients (25 treated, 18 untreated). Of the 43 patients initially enrolled, 38 completed this trial and comprised the final sample, and 5 (4 treated, 1 untreated) were excluded . All patients and parents gave prior informed consent to their inclusion in the investigation.
Patients of both groups were followed on a parallel basis during a period of 8 months and included in the trial regardless of achievement of a Class I incisor relationship. All patient of treatment group (n=21) were treated with FLMGM, and treatment was continued beyond this time point if the Class II malocclusion was not fully corrected and clinical objectives were not achieved. On the other hand, no orthodontic treatment was performed during that duration for the subjects of control group (n=17), and most of control subjects were offered suitable treatment at a later date.
For each patient, a direct digital lateral cephalogram was taken pre- and post- treatment/observation using PAX 400 (VATECH CO., Korea) with the same settings. Cephalograms were digitized on screen and analyzed in a blind manner by the same orthodontist using a cephalometric software (Viewbox, 3.1.1.13, Kifissia). . All linear measurements were reduced to life size (enlargement: 7.54%).
Pretreatment equivalence, changes occurring during the examination period in each group and comparison of changes observed in both groups were tested for significance with t-tests using SPSS . P values of less than 0.05 were considered statistically significant. To assess the method error, twenty cephalograms were randomly picked from both groups and redigitized and analyzed by the same orthodontist after 1 month, and the method error was calculated by Dahlberg's formula.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Class II Division 1 Malocclusion, Retrognathic Mandible
Keywords
Class II division 1 malocclusion, Dentofacial orthopedics, Fixed Lingual Mandibular Growth Modificator (FLMGM)
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
43 (Actual)
8. Arms, Groups, and Interventions
Arm Title
FLMGM Treatment Group
Arm Type
Experimental
Arm Title
Untreated Class II Control Group
Arm Type
No Intervention
Intervention Type
Device
Intervention Name(s)
Fixed Lingual Mandibular Growth Modificator (FLMGM)
Other Intervention Name(s)
Fixed Lingual Mandibular Growth Modification Appliance (FLMGMA)
Intervention Description
Novel Class II functional appliance, a fixed version of double-plate appliance
Primary Outcome Measure Information:
Title
Total Mandibular Length (Co-Gn)
Time Frame
8 months
Secondary Outcome Measure Information:
Title
Overjet Reduction
Time Frame
8 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
11 Years
Maximum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Before treatment, each patient fulfilled the following criteria:
Cl II/1 malocclusion with an overjet greater than 4 mm.
Mild to moderate Class II Skeletal pattern (A-N-B > 4°) with retrognathic mandible (S-N-B < 76°).
Growth potential. Fishman skeletal maturation indicator (SMI) method28 was used to assess the hand-wrist radiographs, and only patients in the peak of the pubertal growth spurt, which occurs on average between SMIs 4 to 7,29 at the beginning of the treatment/observation period were invited.
Exclusion Criteria:
-
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Osama H Alali, PhD
Organizational Affiliation
Senior Lecturer, Department of Orthodontics, School of Dentistry, University of Aleppo, Syria
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Orthodontics, School of Dentistry, University of Damascus
City
Damascus
Country
Syrian Arab Republic
12. IPD Sharing Statement
Learn more about this trial
Fixed Lingual Mandibular Growth Modificator
We'll reach out to this number within 24 hrs